Navigation Links
Loosen leash on cancer protein 'watchdog,' researchers say

p came together, Mendrysa said, they were primarily concerned with how they might stop their prospective protein watchdog from doing more harm than good.

"Research is turning up lots of possible inroads for combating disease these days, and other research teams had found that p53 was a good prospect for fighting cancer," she said. "With too little p53 protein, people and mice are more likely to develop cancer. But it's not a panacea. Embryonic mice with too much p53 in their systems don't survive gestation. Moreover, recent reports have suggested that high levels of p53 may accelerate aging. Having the wrong amount of p53 protein, therefore, leaves you with two potentially unappealing choices: Do you want to die early of cancer or die early from wearing your body out?"

The scientists theorized that the solution could lie with another protein the body produces naturally to keep p53 in check. This other protein, called Mdm2, keeps p53 inactive until it is needed, acting like a leash on a watchdog.

"p53 seems to be an important stress response gene that fights cancer when it works," Mendrysa said. "So we decided to see what we could do to increase p53's activity without completely cutting its Mdm2 leash."

The scientists spent three years creating a strain of genetically modified mouse that only produced about 20 percent of the normal amount of Mdm2 protein, which is far less than they would have produced under ordinary conditions. The mice were created to answer a twofold question: Could increasing their levels of p53 delay or prevent tumor formation in living creatures, and would there be any negative consequences to the increase?

"We were primarily interested in the second part of the question when we began," Mendrysa said. "These mice had a family trait that typically made them develop cancerous lesions in their intestines, but our main goal was to see whether p53 sped up the aging process. Fortunately, we got more kinds of go
'"/>

Source:Purdue University


Page: 1 2 3 4

Related biology news :

1. Loosen up, DNA: Leukemia gene changes genetic packaging
2. How an AIDS-Related Cancer Unleashes Inflammation
3. Viral DNA sequence a possible trigger for breast cancer
4. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
5. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Combination therapy boosts effectiveness of telomere-directed cancer cell death
8. Mitochondrial DNA mutations play significant role in prostate cancer
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. BRCA1 causes ovarian cancer through indirect, biochemical route
11. Researchers identify target for cancer drugs

Post Your Comments:
(Date:11/4/2009)...ss., Oct. 20 Aware, Inc.... technology and biometrics software, today reporte...eptember 30, 2009. ,, Michael Tzannes, Aware,...lier today, we announced an agreement to sell our ... new fabless semiconductor company being spun out ...
(Date:11/4/2009)... Oct. 26 BIO-key Interna...in finger-based biometric identification software ... at the AABB TXPO conference being held at the New.... BIO-key will provide hands-on product demonstrat...logy in booth #424. Also, at 5 PM on Monday, Octob...
(Date:11/4/2009)...alif., Nov. 4 GenVault Corporation..., M.D., Ph.D., has joined its Board of Directors. ... the Salk Institute, is an acclaimed physician-sci...e Salk Institute, Dr. Brody served as president of...the National Academy of Engineering and the Instit...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3ReBuilder Medical Technologies Inc s Dr Phillips to Speak to Ohio Investment Group 55711 1ReBuilder Medical Technologies Inc s Dr Phillips to Speak to Ohio Investment Group 55711 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 1CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 3Hard To Treat Diseases 28HTDS PK 29 50 000 doses of Mevac A To Sri Lanka 55705 1Hard To Treat Diseases 28HTDS PK 29 50 000 doses of Mevac A To Sri Lanka 55705 2Hard To Treat Diseases 28HTDS PK 29 50 000 doses of Mevac A To Sri Lanka 55705 3Hard To Treat Diseases 28HTDS PK 29 50 000 doses of Mevac A To Sri Lanka 55705 4
...sing an extremely fast and accurate imaging techni...ular motors that shuttle material within living ce...hy of steps, rather than engaging in the brute-for... discovered that two molecular motors -- dynein an...gh they want to move the same cargo in opposite di...
...t Yale, in collaboration with NIH researchers, hav...sed by the immune system for detection of parasiti...uture vaccines to combat these infections. , Publi... study provides insight into understanding how inf...--a problem of great scientific and clinical impor...
...the first clinical trial of a therapeutic cancer v...nce, CpG 7909 (ProMuneTM, Coley Pharmaceutical), w...ournal of Clinical Investigation. The paper shows ...ses the immune system,s ability to recognize and d...ed by the Lausanne Branch of the Ludwig Institute ...
Other Biology News:Molecular Motors Cooperate In Moving Cellular Cargo, Study Shows 2Yale researchers identify molecule for detecting parasitic infection in humans 2Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy 2
(Date:11/6/2009)...irstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP...Docherty, president and chief operating officer, w...nvestor Summit on November 10, 2009 at 4:00 PM at ...will provide an overview of the Company,s leading ...nterferon Alpha-2b. The slide show portion of the...
(Date:11/6/2009)...wire/ -- Calbiotech, Inc. announced today that it ...rch (SBIR) Phase I contract by the U.S. Army Medic...he agreement, Calbiotech will develop analyte spec...irus. ,, Dengue virus is a mosquito-born fla... forces deployed to tropical areas of the world. D...
(Date:11/5/2009)..., Fuel economy ratings for the new 2010 model ye...omy.gov web site, which Oak Ridge National Labora...nt of Energy and the U.S. Environmental Protection...uel economy list are hybrid electrics, led by the ... proves that hybrids have gone mainstream," said p...
(Date:11/5/2009)...ll/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX)...and CEO of Imagenetix, will be presenting the Comp...on Thursday, December 3rd, at 10:30 AM PST at the ..., LD MICRO is a by-invitation only newsletter f...in the micro-cap space. Since 2002, the firm has p...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...FirstCall/ -- Max Nutrition Inc.,(OTC Bulletin Boa...Company,has completed the share exchange (the "Clo...nization with American Spring Pharmaceutical, Inc.... Agreement, ASPI transferred,100% of the issued an...Technology Stock Co., Ltd ("GDBS") to the Company ...
...Fresne, Chairman,and CEO of Egenix, Inc., announce...m Harvard University a field-exclusive license und...elated to cancer therapy and,prognostic testing. T...ntly,by scientists in the Laboratory for Translati...mistry and Molecular Pharmacology, each of,Harvard...
...ce more competition from private ... Venture capitalists will largely,direct their inv...n the,coming year, while China and India remain ho...ecent survey by the U.S. audit, tax and advisory,f...apitalists, entrepreneurs, corporate,buyers, inves...
Other Biology Technology:Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc. 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 3
...rification system, 100-120 V, is used for protein ...ctric focusing (IEF). The system includes both the...rs, chassis, harvesting apparatus, cooling finger,... 3-10), 60 ml syringe, colored protein sample, 2 v...
...n, a hydrophobic barrier pen for immunohistochemis...e with frozen or paraffin-embedded tissue sections... a heat-stable, water-repellent barrier that keeps...s, prevents mixing of reagents when differentially...
NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
...llBIND surface is produced by a patented microwave...ving more consistent, even cell attachment, increa... attachment and growth uunder difficult conditions...ull; CellBIND may provide a more ecominic alternat...
Biology Products: